<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="cells, IL2, IL-12, interferon gamma (IFN-Î³), and transforming growth factor" exact="alpha" post="(TGF-Î±), effector cells produce antibodies to destroy the infected"/>
 <result pre="the trialed antiviral drugs, remdesivir alone or in combination with" exact="chloroquine" post="or interferon beta showed effectiveness against COVID-19 infection (Sheahan"/>
 <result pre="effectiveness against COVID-19 infection, ganciclovir, acyclovir, ribavirin, oseltamivir, peramivir, and" exact="zanamivir" post="are not promising options to treat COVID-19. However, remdesivir,"/>
 <result pre="infection (Chan et al., 2020). Previous studies have shown that" exact="chloroquine" post="(broadly used antimalarial drug) exhibits antiviral properties against several"/>
 <result pre="SARS-CoV-2 (Colson et al., 2020). However, the toxic effects of" exact="chloroquine" post="such as increasing the risk for cardiovascular disorders have"/>
 <result pre="the Chinese Clinical Trial Registry (www.chictr.org.cn), proposing the use of" exact="chloroquine" post="in controlling COVID-19 (under registration numbers: ChiCTR-20000-29542, 29559, 29609,"/>
 <result pre="could be a target to prevent viral entry. Moreover, Transmembrane" exact="Serine" post="Protease 2 (TMPRSS2) is helper membrane protein for the"/>
 <result pre="Human Coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13bioRxiv20209690062020.2002, 2027 MatsuyamaS.KawaseM.NaoN.ShiratoK.UjikeM.KamitaniW.ShimojimaM.FukushiS.The Inhaled Corticosteroid" exact="Ciclesonide" post="Blocks Coronavirus RNA Replication by Targeting Viral NSP15bioRxiv202010.1101/03.11.9870162020 MengL.HuaF.BianZ.Coronavirus"/>
</results>
